Meeting Conferences
Publications|Meeting ConferencesNew factor VIII-function mimetic antibodies engineered from emicizumab for further improving the treatment of hemophilia A
Speaker: Yuri Teranishi
Conference: ISTH 2020
Drug discovery using recycling and sweeping antibody technology (Poster)
Speaker: Naoka Hironiwa
Conference: 2nd Antibody Engineering and Therapeutics Asia 2020
Drug discovery using bispecific and asymmetric antibody technology
Speaker: Yuri Teranishi
Conference: 2nd Antibody Engineering and Therapeutics Asia 2020
Drug discovery using recycling and sweeping antibody technology (Oral)
Speaker: Naoka Hironiwa
Conference: 2nd Antibody Engineering and Therapeutics Asia 2020
Anti-HPV16 E7 peptide MHC I antibody identification for T cell bispecifics by Rabbit single B cell cloning
Speaker: Noriyuki Takahashi
Conference: 2nd Antibody Engineering and Therapeutics Asia 2020
New factor VIII function-mimetic bispecific antibodies engineered from emicizumab for further improving the treatment of hemophilia A
Speaker: Yuri Teranishi
Conference: 2nd Antibody engineering and therapeutics Asia 2020
Novel antibody engineering to improve therapeutic index of antibody targeting solid tumor
Speaker: Futa Mimoto
Conference: 7th Antibody Symposium 2020
New factor VIII function-mimetic bispecific antibodies engineered from emicizumab for further improving the treatment of hemophilia A
Speaker: Tomoyuki Igawa
Conference: 7th Antibody Symposium 2020
Cellular and analytical assays for PK engineering
Speaker: Lam Runyi Adeline
Conference: PepTalk 2019
Humanized anti-FIXa/FX bispecific antibody for the treatment of hemophilia A and beyond
Speaker: Yuri Teranishi
Conference: Antibody Engineering and Therapeutics Asia 2019
Drug discovery driven by antibody engineering technologies
Speaker: Tomoyuki Igawa
Conference: 1st Antibody Engineering & Therapeutics Asia 2019
Drug Discovery driven by antibody engineering technologies
Speaker: Tomoyuki Igawa
Conference: 第12回 ミッドウィンターセミナー2019
Lead antibody identification against membrane protein targets using Rabbit single B cell cloning technology
Speaker: Noriyuki Takahashi
Conference: Discovery on Target 2019
Isoelectric point engineering to enhance the potency of therapeutic antibody
Speaker: Taichi Kuramochi
Conference: Antibody Engineering & Therapeutics 2019
Sweeping antibodytechnology to enhance the potency of therapeutic antibody
Speaker: Taichi Kuramochi
Conference: 6th Antibody Symposium 2019
Novel antibody engineering to improve therapeutic index of antibody targeting solid tumor
Speaker: Futa Mimoto
Conference: Antibody Engineering and Therapeutics Conference 2019
Anti-GPRC5D/CD3 bispecific T cell-redirecting antibody for the treatment of multiple myeloma
Speaker: Tatsushi Kodama
Conference: 6th Antibody Symposium 2019
Anti-HPV16 E7 peptide MHC I antibody identification for T cell bispecifics by Rabbit single B cell cloning
Speaker: Noriyuki Takahashi
Conference: Antibody Engineering and Therapeutics 2018
次世代医薬等基盤技術
Speaker: Tomoyuki Igawa
Conference: JSTCDRS ライフサイエンス 臨床医学分野 2018
Bispecific antibody as next generation antibody therapeutics Emicizumab (anti-FIXa/FX bispecific antibody), ERY 974 (anti-GPC3/CD3) bispecific antibody
Speaker: Tomoyuki Igawa
Conference: Gordon Conference、Poster 2018
Antibody engineering technologies to solve unmet medical needs
Speaker: Tomoyuki Igawa
Conference: Gordon Conference、Oral 2018
Discovery and development of therapeutic bispecific antibodies
Speaker: Tomoyuki Igawa
Conference: EpiVax Seminar 2018
Discovery and development of therapeutic bispecific antibodies
Speaker: Tomoyuki Igawa
Conference: 日本医療学会年会 2018
Novel Cell-based assays for PK screening during antibody optimisation
Speaker: Lam Runyi Adeline
Conference: Antibody Engineering & Therapeutics 2018
Tricks to enhance bispecific antibody purification by using Protein L chromatography
Speaker: Yuichiro Shimizu
Conference: Peptalk 2018
Tricks to enhance bispecific antibody purification by using Protein L chromatography
Speaker: Yuichiro Shimizu
Conference: Peptalk 2018
Application of Biacore in pH dependent Ab screening
Speaker: Gan Siok Wan
Conference: DIPIA 2018
Efficient B cell cloning and antibody engineering platform for rare Ab generation
Speaker: Feng Shu
Conference: Peptalk 2018
Isoelectric point engineering to enhance the potency of an antibody with pH-dependent antigen binding
Speaker: Taichi Kuramochi
Conference: Antibody Engineering & Therapeutics 2017
Rabbit single B-cell cloning platform in Chugai
Speaker: Noriyuki Takahashi
Conference: Antibody Engineering and Therapeutics 2017
Continuous innovative drug discovery utilizing antibody engineering technology
Speaker: Tomoyuki Igawa
Conference: BioJapan 2017
Drug discovery of antibody therapeutics and research activities in Chugai Pharmabody Research
Speaker: Tomoyuki Igawa
Conference: 日本大使館主催JCC科学技術講演会 2017
Optimization strategy to generate antibody with high solubility and low viscosity for SC formulation
Speaker: Masaru Muraoka
Conference: 13th PEGS Boston 2017
Modeling and simulation analysis of a novel engineered therapeutic antibody with PH-dependent binding to target antigen
Speaker: Kenta Haraya
Conference: 11th International ISSX Meeting 2016
Lead Identification function: Powerful antibody discovery platform with B-cell cloning and high throughput screening to identify rarest and most valuable lead antibody
Speaker: Yoshinao Ruike
Conference: 3rd Antibody Symposium 2015
Antibody drug discovery research to create new value
Speaker: Meiri Kawazoe
Conference: 第32回JASSセミナー 2015
Advanced characterization of biotherapeutics
Speaker: Meiri Kawazoe
Conference: 3rd Antibody Symposium 2015
Optimal formulation design of antibody drugs for subcutaneous delivery to provide patients with great value
Speaker: Meiri Kawazoe
Conference: 3rd Antibody Symposium 2015
Lead optimization function: “Antibody Crafting” with high through-put comprehensive mutagenesis approach
Speaker: Feng Shu
Conference: 3rd Antibody Symposium 2015
Protein Production function: step-by-step solutions for different bottlenecks of gram-scale antibody production to accelerate drug discovery processes
Speaker: Yuichiro Shimizu
Conference: 3rd Antibody Symposium 2015
Antibody expression and purification platform for early-stage R&D
Speaker: Yuichiro Shimizu
Conference: BioPharmaAsia convention 2014
Generation of an asymmetric bispecific IgG antibody mimicking the function of FVIII cofactor activity for the treatment of hemophilia A
Speaker: Zenjiro Sampei
Conference: 10th PEGS
Chugai’s proprietary antibody engineering technologies
Speaker: Junichi Nezu
Conference: 1st Taiwan-Japan Joint Conference on the Development of Therapeutic Antibodies 2014
Utilization of empower network for superior research environment
Speaker: Meiri Kawazoe
Conference: 1st Singapore separation User Forum 2014
PK optimization and preclinical PK of novel bispecific antibody against FIXa and X for the treatment of hemophilia A
Speaker: Kenta Haraya
Conference: Second Annual PK/PD of Multi-Domain Proteins conference, PEGS 2014
Engineered Antibody to Sweep Antigen by pH-Dependent Antigen Binding and Increased FcRn Binding
Speaker: Tatsuhiko Tachibana
Conference: 19th North American Regional ISSX Meeting and 29th JSSX Annual Meeting 2014
Solution based kinetics & affinity assay for Ab/Ag interaction: Assay development using Octet quantitation assay
Speaker: Gan Siok Wan
Conference: 1st Pall-forteBio Antibody Workshop 2014
Clarification of cell culture supernatant using BioOptimal MF-SL in early-stage R&D
Speaker: Yuichiro Shimizu
Conference: 17th Planova workshop 2014
SMART-Ig; novel antibody recycling technology by engineering endosomal antigen dissociation
Speaker: Junichi Nezu
Conference: Drug Discovery World Asia 2013
Antibody drug discovery process in CPR based on recycling & sweeping antibody technology
Speaker: Junichi Nezu
Conference: Antibody Engineering Asia 2013
Engineered monoclonal antibody with novel antigen-sweeping activity in vivo
Speaker: Tatsuhiko Tachibana
Conference: 2nd ADME BioTx 2nd Workshop 2013
Generation of an asymmetric bispecific IgG antibody that restores factor VIII hemostatic activity in a hemophilia A model
Speaker: Zenjiro Sampei
Conference: 2nd Antibody Symposium 2013
Virtual clinical trial-prediction of interindividual variability in pharmacokinetics of CYP2C8 substrates
Speaker: Kenta Haraya
Conference: JSSX 2013
Antibody drug discovery process in CPR based on recycling & sweeping antibody technology
Speaker: Junichi Nezu
Conference: 1st Antibody Symposium 2012
